Clinical Cancer Research Bridging the Lab and the Clinic in Cancer Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernacki, R. J.
Right arrow Articles by Porter, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernacki, R. J.
Right arrow Articles by Porter, C. W.

Clinical Cancer Research, Vol 1, Issue 8 847-857, Copyright © 1995 by American Association for Cancer Research


ARTICLES

Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion

RJ Bernacki, EJ Oberman, KE Seweryniak, A Atwood, RJ Bergeron and CW Porter
Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263, and Department of Medicinal Chemistry, University of Florida, Gainesville, Florida 32610, USA.

Certain N-alkylated analogues of the natural polyamine spermine have been found to disrupt polyamine pool homeostasis and inhibit tumor cell growth. The most effective of these analogues, N1, N11-diethylnorspermine (DENSPM), apparently depletes intracellular polyamine pools primarily by inducing the polyamine acetylating enzyme spermidine/spermine N1-acetyltransferase, which contributes to polyamine depletion via increased polyamine excretion and catabolism. In this report, the experimental therapeutic efficacy of DENSPM was further examined with the use of other human solid tumor xenografts, including A121 ovarian carcinoma, A549 lung adenocarcinoma, HT29 colon carcinoma, and SH-1 melanoma, and compared with previously obtained findings with MALME-3M and PANUT-3 human melanomas. In vitro studies indicated that the growth sensitivity of most tumor cell lines to DENSPM was similar, with characteristically flat dose-response curves and IC50s ranging between 0.1 and 1 micrometer the only exception was the HT29 colon carcinoma cell line, which had an IC50 of >100 micrometer. For in vivo studies, DENSPM was administered by i.p. injection to female nude athymic mice at 40 and/or 80 mg/kg 3 times a day (every 8 h) for 6 days or by continuous s.c. infusion with the use of Alzet pumps at 120, 240, or 360 mg/kg/day for 4 days. Treatment began after s.c. tumor xenografts had reached 100-200 mm3. The SH-1 melanoma, A549 lung adenocarcinoma, and A121 ovarian carcinoma xenografts responded well to the i.p. administration of analogue with obvious tumor regressions, long-term tumor growth suppressions, and a significant proportion (up to 40%) of apparent cures (i.e., lack of tumor regrowth). However, in similarity to in vitro findings, HT29 colon carcinoma xenografts responded poorly to DENSPM treatment. Massive induction of N1-acetyltransferase activity and extensive depletion of polyamine pools were consistent findings in most tumor types after in vivo or in vitro treatment with DENSPM. The rapidly growing human LOX melanoma xenograft, however, demonstrated poor induction of N1-acetyltransferase activity and the poorest response to DENSPM treatment. In nude athymic mice with MALME-3M melanoma xenografts, constant infusion delivery of DENSPM resulted in prolonged inhibition of tumor growth and long-term tumor regressions comparable to those produced by multiple i.p. injections. On the basis of the unique structure of DENSPM, novel target and mode of intervention, mild host toxicity, and activity against different human solid tumor xenografts, DENSPM is currently being developed as an antitumor agent in humans.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. T. Hyvonen, T. A. Keinanen, M. Cerrada-Gimenez, R. Sinervirta, N. Grigorenko, A. R. Khomutov, J. Vepsalainen, L. Alhonen, and J. Janne
Role of Hypusinated Eukaryotic Translation Initiation Factor 5A in Polyamine Depletion-induced Cytostasis
J. Biol. Chem., November 30, 2007; 282(48): 34700 - 34706.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Pirinen, T. Kuulasmaa, M. Pietila, S. Heikkinen, M. Tusa, P. Itkonen, S. Boman, J. Skommer, A. Virkamaki, E. Hohtola, et al.
Enhanced Polyamine Catabolism Alters Homeostatic Control of White Adipose Tissue Mass, Energy Expenditure, and Glucose Metabolism
Mol. Cell. Biol., July 1, 2007; 27(13): 4953 - 4967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. Zahedi, J. J. Bissler, Z. Wang, A. Josyula, L. Lu, P. Diegelman, N. Kisiel, C. W. Porter, and M. Soleimani
Spermidine/spermine N1-acetyltransferase overexpression in kidney epithelial cells disrupts polyamine homeostasis, leads to DNA damage, and causes G2 arrest
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1204 - C1215.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
W. L. Allen, E. G. McLean, J. Boyer, A. McCulla, P. M. Wilson, V. Coyle, D. B. Longley, R. A. Casero Jr., and P. G. Johnston
The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells
Mol. Cancer Ther., January 1, 2007; 6(1): 128 - 137.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
Y. Wang and R. A. Casero Jr.
Mammalian Polyamine Catabolism: A Therapeutic Target, a Pathological Problem, or Both?
J. Biochem., January 1, 2006; 139(1): 17 - 25.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. T. Hyvonen, K.-H. Herzig, R. Sinervirta, E. Albrecht, I. Nordback, J. Sand, T. A. Keinanen, J. Vepsalainen, N. Grigorenko, A. R. Khomutov, et al.
Activated Polyamine Catabolism in Acute Pancreatitis: {alpha}-Methylated Polyamine Analogues Prevent Trypsinogen Activation and Pancreatitis-Associated Mortality
Am. J. Pathol., January 1, 2006; 168(1): 115 - 122.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. M. Tucker, J. T. Murphy, N. Kisiel, P. Diegelman, K. W. Barbour, C. Davis, M. Medda, L. Alhonen, J. Janne, D. L. Kramer, et al.
Potent Modulation of Intestinal Tumorigenesis in Apcmin/+ Mice by the Polyamine Catabolic Enzyme Spermidine/Spermine N1-acetyltransferase
Cancer Res., June 15, 2005; 65(12): 5390 - 5398.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Jarvinen, N. Grigorenko, A. R. Khomutov, M. T. Hyvonen, A. Uimari, J. Vepsalainen, R. Sinervirta, T. A. Keinanen, S. Vujcic, L. Alhonen, et al.
Metabolic Stability of {alpha}-Methylated Polyamine Derivatives and Their Use as Substitutes for the Natural Polyamines
J. Biol. Chem., February 25, 2005; 280(8): 6595 - 6601.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kee, B. A. Foster, S. Merali, D. L. Kramer, M. L. Hensen, P. Diegelman, N. Kisiel, S. Vujcic, R. V. Mazurchuk, and C. W. Porter
Activated Polyamine Catabolism Depletes Acetyl-CoA Pools and Suppresses Prostate Tumor Growth in TRAMP Mice
J. Biol. Chem., September 17, 2004; 279(38): 40076 - 40083.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
C. J. Bacchi, D. Rattendi, E. Faciane, N. Yarlett, L. M. Weiss, B. Frydman, P. Woster, B. Wei, L. J. Marton, and M. Wittner
Polyamine metabolism in a member of the phylum Microspora (Encephalitozoon cuniculi): effects of polyamine analogues
Microbiology, May 1, 2004; 150(5): 1215 - 1224.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. C. Wolff, D. K. Armstrong, J. H. Fetting, M. K. Carducci, C. D. Riley, J. F. Bender, R. A. Casero Jr., and N. E. Davidson
A Phase II Study of the Polyamine Analog N1,N11-Diethylnorspermine (DENSpm) Daily for Five Days Every 21 Days in Patients with Previously Treated Metastatic Breast Cancer
Clin. Cancer Res., December 1, 2003; 9(16): 5922 - 5928.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Niiranen, M. Pietila, T. J. Pirttila, A. Jarvinen, M. Halmekyto, V.-P. Korhonen, T. A. Keinanen, L. Alhonen, and J. Janne
Targeted Disruption of Spermidine/Spermine N1-Acetyltransferase Gene in Mouse Embryonic Stem Cells. EFFECTS ON POLYAMINE HOMEOSTASIS AND SENSITIVITY TO POLYAMINE ANALOGUES
J. Biol. Chem., July 5, 2002; 277(28): 25323 - 25328.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. A. Hahm, D. S. Ettinger, K. Bowling, B. Hoker, T. L. Chen, Y. Zabelina, and R. A. Casero Jr.
Phase I Study of N1,N11-Diethylnorspermine in Patients with Non-Small Cell Lung Cancer
Clin. Cancer Res., March 1, 2002; 8(3): 684 - 690.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. A. Hahm, V. R. Dunn, K. A. Butash, W. L. Deveraux, P. M. Woster, R. A. Casero Jr., and N. E. Davidson
Combination of Standard Cytotoxic Agents with Polyamine Analogues in the Treatment of Breast Cancer Cell Lines
Clin. Cancer Res., February 1, 2001; 7(2): 391 - 399.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Wang, W. Devereux, T. M. Stewart, and R. A. Casero Jr.
Cloning and Characterization of Human Polyamine-modulated Factor-1, a Transcriptional Cofactor That Regulates the Transcription of the Spermidine/Spermine N1-Acetyltransferase Gene
J. Biol. Chem., July 30, 1999; 274(31): 22095 - 22101.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. W. Gabrielson, A. E. Pegg, and R. A. Casero Jr.
The Induction of Spermidine/Spermine N1-Acetyltransferase (SSAT) Is a Common Event in the Response of Human Primary Non-Small Cell Lung Carcinomas to Exposure to the New Antitumor Polyamine Analogue N1,N11-Bis(ethyl)norspermine1
Clin. Cancer Res., July 1, 1999; 5(7): 1638 - 1641.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Alhonen, M. Pietilä, M. Halmekytö, D. L. Kramer, J. Jänne, and C. W. Porter
Transgenic Mice with Activated Polyamine Catabolism due to Overexpression of Spermidine/Spermine N1-Acetyltransferase Show Enhanced Sensitivity to the Polyamine Analog, N1,N11-Diethylnorspermine
Mol. Pharmacol., April 1, 1999; 55(4): 693 - 698.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Wang, L. Xiao, A. Thiagalingam, B. D. Nelkin, and R. A. Casero Jr.
The Identification of a Cis-element and a Trans-acting Factor Involved in the Response to Polyamines and Polyamine Analogues in the Regulation of the Human Spermidine/Spermine N1-Acetyltransferase Gene Transcription
J. Biol. Chem., December 18, 1998; 273(51): 34623 - 34630.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Alhonen, A. Karppinen, M. Uusi-Oukari, S. Vujcic, V.-P. Korhonen, M. Halmekyto, D. L. Kramer, R. Hines, J. Janne, and C. W. Porter
Correlation of Polyamine and Growth Responses to N1,N11-Diethylnorspermine in Primary Fetal Fibroblasts Derived from Transgenic Mice Overexpressing Spermidine/Spermine N1-Acetyltransferase
J. Biol. Chem., January 23, 1998; 273(4): 1964 - 1969.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Pietila, L. Alhonen, M. Halmekyto, P. Kanter, J. Janne, and C. W. Porter
Activation of Polyamine Catabolism Profoundly Alters Tissue Polyamine Pools and Affects Hair Growth and Female Fertility in Transgenic Mice Overexpressing Spermidine/Spermine N1-Acetyltransferase
J. Biol. Chem., July 25, 1997; 272(30): 18746 - 18751.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Fogel-Petrovic, D. L. Kramer, S. Vujcic, J. Miller, J. S. Mcmanis, R. J. Bergeron, and C. W. Porter
Structural Basis for Differential Induction of Spermidine/Spermine N1-Acetyltransferase Activity by Novel Spermine Analogs
Mol. Pharmacol., July 1, 1997; 52(1): 69 - 74.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Alhonen, J. J. Parkkinen, T. Keinanen, R. Sinervirta, K.-H. Herzig, and J. Janne
Activation of polyamine catabolism in transgenic rats induces acute pancreatitis
PNAS, July 18, 2000; 97(15): 8290 - 8295.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.